arrow_backBack to Catalogue
Metabolic / Fat Loss
AOD9604
Modified hGH Fragment isolating lipolytic properties without growth-promoting effects.
Clinical Profile
- check_circleTargeted visceral and abdominal fat loss
- check_circleZero impact on blood sugar or insulin sensitivity
- check_circleNo growth-promoting side effects
- check_circleFDA GRAS status (Generally Recognized As Safe)
biotech
Mechanism of Action
A 16-amino acid peptide that isolates the fat-burning (lipolytic) properties of human growth hormone. It works by stimulating lipolysis via beta-3 adrenergic receptor upregulation and inhibiting lipogenesis (new fat creation) without affecting IGF-1, glucose tolerance, or growth signaling.
medication_liquid
Therapeutic Application
Typically administered via subcutaneous injection daily, ideally 30 minutes before the first meal of the day while fasting.
Ready to include AOD9604 in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.